Matches in SemOpenAlex for { <https://semopenalex.org/work/W2077895866> ?p ?o ?g. }
- W2077895866 endingPage "1566" @default.
- W2077895866 startingPage "1557" @default.
- W2077895866 abstract "1. The dose-related inhibition of the twitch responses of the myenteric plexus-longitudinal muscle preparation of the guinea-pig small intestine by cannabinoid (CB) agonists, (+)-WIN 55212 and CP 55940 during stimulation at 0.1 Hz with supramaximal voltage was confirmed. These agonists inhibited acetylcholine (ACh) release in the presence of physostigmine (7.7 microM) thus indicating a prejunctional site of action. 2. Inhibition of twitch responses and ACh release by CB agonists was reversed by the CB1-selective cannabinoid receptor antagonist, SR141716A. Dose-response curves to (+)-WIN 55212 and CP 55940 were shifted to the right, with no reduction of maximal response, by pretreatment with SR141716A (31.6-1000 nM), but not its vehicle, Tween 80 (1 microM). However, at very high concentrations (25-400 microM), Tween 80 itself caused a dose-related inhibition of the twitch response which was significantly reduced in the presence of SR141716A (1 microM). The opioid receptor antagonist, naloxone (1 microM) had no significant effect on the inhibition by CP 55940 of the twitch response. 3. (+)-WIN 55212, CP 55940 and Tween 80 (50 microM) had no effect on responses to exogenous ACh, confirming that their actions were prejunctional. SR141716A (1 microM) did not increase the sensitivity of the longitudinal muscle to either ACh or histamine, but inhibited the responses to high doses of ACh. 4. The (-)-enantiomer of WIN 55212, was approximately 300 times less active than the (+) enantiomer in inhibiting the twitch response, had no CB1 antagonist activity against the active isomer and did not inhibit the release of ACh in the presence of physostigmine. 5. The dissociation constant (KD) values for SR 141716A against the inhibitory effect of (+)-WIN 55212 and CP 55940 on the twitch response were 12.07 nM (95% confidence intervals 8.55 and 20.83) and 6.44 nM (95% confidence intervals 4.70 and 10.24), respectively. In experiments in which the release of ACh was inhibited by (+)-WIN 55212, the KD values were 9.21 nM and 10.53 nM at SR141716A concentrations of 31.6 nM and 100 nM, respectively. The KD values for the antagonism by naloxone of the inhibition of the twitch responses and the inhibition of ACh release by normorphine in this preparation were found to be 2.38 +/- 0.69 nM and 2.00 +/- 0.9 nM, respectively. 6. During maximal inhibition of ACh release by (+)-WIN 55212, the addition of normorphine (400 nM) caused a further significant decrease in ACh output. 7. SR141716A alone produced a significant increase in ACh release in both the absence and presence of exogenous cannabinoid drugs, hence we conclude that it has a presynaptic site of action. We also conclude that SR141716A acts either by antagonizing the effect of an endogenous CB1 receptor agonist or by having an inverse agonist effect at these receptors." @default.
- W2077895866 created "2016-06-24" @default.
- W2077895866 creator A5033722934 @default.
- W2077895866 creator A5042677194 @default.
- W2077895866 date "1997-08-01" @default.
- W2077895866 modified "2023-10-14" @default.
- W2077895866 title "Inhibition by cannabinoid receptor agonists of acetylcholine release from the guinea-pig myenteric plexus" @default.
- W2077895866 cites W1965835906 @default.
- W2077895866 cites W1986178334 @default.
- W2077895866 cites W1989073099 @default.
- W2077895866 cites W2003863708 @default.
- W2077895866 cites W2008189050 @default.
- W2077895866 cites W2012633994 @default.
- W2077895866 cites W2018909032 @default.
- W2077895866 cites W2024653583 @default.
- W2077895866 cites W2030884112 @default.
- W2077895866 cites W2043303731 @default.
- W2077895866 cites W2044737826 @default.
- W2077895866 cites W2059977407 @default.
- W2077895866 cites W2063269320 @default.
- W2077895866 cites W2071712193 @default.
- W2077895866 cites W2072721884 @default.
- W2077895866 cites W2075811628 @default.
- W2077895866 cites W2080809363 @default.
- W2077895866 cites W2085741941 @default.
- W2077895866 cites W2086616710 @default.
- W2077895866 cites W2086691685 @default.
- W2077895866 cites W2169723022 @default.
- W2077895866 doi "https://doi.org/10.1038/sj.bjp.0701301" @default.
- W2077895866 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1564859" @default.
- W2077895866 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9283688" @default.
- W2077895866 hasPublicationYear "1997" @default.
- W2077895866 type Work @default.
- W2077895866 sameAs 2077895866 @default.
- W2077895866 citedByCount "143" @default.
- W2077895866 countsByYear W20778958662012 @default.
- W2077895866 countsByYear W20778958662014 @default.
- W2077895866 countsByYear W20778958662015 @default.
- W2077895866 countsByYear W20778958662016 @default.
- W2077895866 countsByYear W20778958662017 @default.
- W2077895866 countsByYear W20778958662018 @default.
- W2077895866 countsByYear W20778958662019 @default.
- W2077895866 countsByYear W20778958662020 @default.
- W2077895866 countsByYear W20778958662021 @default.
- W2077895866 countsByYear W20778958662022 @default.
- W2077895866 crossrefType "journal-article" @default.
- W2077895866 hasAuthorship W2077895866A5033722934 @default.
- W2077895866 hasAuthorship W2077895866A5042677194 @default.
- W2077895866 hasBestOaLocation W20778958661 @default.
- W2077895866 hasConcept C126322002 @default.
- W2077895866 hasConcept C134018914 @default.
- W2077895866 hasConcept C148001335 @default.
- W2077895866 hasConcept C170493617 @default.
- W2077895866 hasConcept C185592680 @default.
- W2077895866 hasConcept C204232928 @default.
- W2077895866 hasConcept C2775910092 @default.
- W2077895866 hasConcept C2776907353 @default.
- W2077895866 hasConcept C2778815084 @default.
- W2077895866 hasConcept C2778938600 @default.
- W2077895866 hasConcept C2780871563 @default.
- W2077895866 hasConcept C2910065304 @default.
- W2077895866 hasConcept C55493867 @default.
- W2077895866 hasConcept C71924100 @default.
- W2077895866 hasConcept C98274493 @default.
- W2077895866 hasConceptScore W2077895866C126322002 @default.
- W2077895866 hasConceptScore W2077895866C134018914 @default.
- W2077895866 hasConceptScore W2077895866C148001335 @default.
- W2077895866 hasConceptScore W2077895866C170493617 @default.
- W2077895866 hasConceptScore W2077895866C185592680 @default.
- W2077895866 hasConceptScore W2077895866C204232928 @default.
- W2077895866 hasConceptScore W2077895866C2775910092 @default.
- W2077895866 hasConceptScore W2077895866C2776907353 @default.
- W2077895866 hasConceptScore W2077895866C2778815084 @default.
- W2077895866 hasConceptScore W2077895866C2778938600 @default.
- W2077895866 hasConceptScore W2077895866C2780871563 @default.
- W2077895866 hasConceptScore W2077895866C2910065304 @default.
- W2077895866 hasConceptScore W2077895866C55493867 @default.
- W2077895866 hasConceptScore W2077895866C71924100 @default.
- W2077895866 hasConceptScore W2077895866C98274493 @default.
- W2077895866 hasIssue "8" @default.
- W2077895866 hasLocation W20778958661 @default.
- W2077895866 hasLocation W20778958662 @default.
- W2077895866 hasLocation W20778958663 @default.
- W2077895866 hasOpenAccess W2077895866 @default.
- W2077895866 hasPrimaryLocation W20778958661 @default.
- W2077895866 hasRelatedWork W1987722050 @default.
- W2077895866 hasRelatedWork W1989787033 @default.
- W2077895866 hasRelatedWork W2005656319 @default.
- W2077895866 hasRelatedWork W2024706171 @default.
- W2077895866 hasRelatedWork W2077895866 @default.
- W2077895866 hasRelatedWork W2081438904 @default.
- W2077895866 hasRelatedWork W2156052800 @default.
- W2077895866 hasRelatedWork W2555906375 @default.
- W2077895866 hasRelatedWork W2901260704 @default.
- W2077895866 hasRelatedWork W4206265980 @default.
- W2077895866 hasVolume "121" @default.
- W2077895866 isParatext "false" @default.
- W2077895866 isRetracted "false" @default.